Go to Page # Page of 18

The Human Touch: a Patient-Centric Injection Device

 Molly Story PhD
Description: The goal is to ensure that the device user interface has been designed such that use errors that occur during use of the device that could cause harm or degrade medical treatment are either eliminated or reduced to the extent possible.
Views: 782
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: PFS & Injectables Summit
 ‐ More of their Presentations
Photo credits: ©

The Human Touch: Develop a
Patient-Centric Injection Device
Molly Story, PhD – 27 September 2017

Why should we care about being patient-centric?
•The FDA tells us:
•Our drugs must be safe and efficacious;
•Our drug delivery devices must be safe
and effective;
•And we must present the evidence in our
regulatory submissions.

•Is that the only ... See more

Recent Presentations

Novel Checkpoints in Immuno-Oncology

This document has been prepared by Innate Pharma S.A. (the “Company”) solely for the purposes of a presentation to investors concerning the Company. This document is not to be repr

19 March, 2018

Oncolytic Immunotherapeutics Leadership

The presentation and the accompanying oral commentary contain forward-looking statements within the meaning of the relevant securities laws of the Republic of Korea and the United

SillaJen Inc
18 March, 2018

Basket and Umbrella Trial Designs in Oncology

Historically, phase I conducted with mixture of solid tumors, then phase II and III oncology trials were histopathologic focused (e.g. lung cancer study, breast cancer study, etc.)

Eric Polley
17 March, 2018